These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 16670463)
21. Unclassified epithelioid vascular tumor with hemangioendotheliomatous features and lymphatic differentiation. Oshiro Y; Kohashi K; Oda Y; Tsuneyoshi M; Shono Y Pathol Int; 2009 Jun; 59(6):410-4. PubMed ID: 19490473 [TBL] [Abstract][Full Text] [Related]
22. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Breiteneder-Geleff S; Soleiman A; Kowalski H; Horvat R; Amann G; Kriehuber E; Diem K; Weninger W; Tschachler E; Alitalo K; Kerjaschki D Am J Pathol; 1999 Feb; 154(2):385-94. PubMed ID: 10027397 [TBL] [Abstract][Full Text] [Related]
23. Novel marker D2-40, combined with calretinin, CEA, and TTF-1: an optimal set of immunodiagnostic markers for pleural mesothelioma. Mimura T; Ito A; Sakuma T; Ohbayashi C; Yoshimura M; Tsubota N; Okita Y; Okada M Cancer; 2007 Mar; 109(5):933-8. PubMed ID: 17279584 [TBL] [Abstract][Full Text] [Related]
24. Lymphatic vessels identified with podoplanin. Comparison of immunostaining with three different detection systems. Cîmpean AM; Raica M; Izvernariu DA; Tătucu D Rom J Morphol Embryol; 2007; 48(2):139-43. PubMed ID: 17641800 [TBL] [Abstract][Full Text] [Related]
25. Expression of podoplanin and calretinin in meningioma: an immunohistochemical study. Shintaku M; Honda T; Sakai T Brain Tumor Pathol; 2010 Apr; 27(1):23-7. PubMed ID: 20425044 [TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical diagnosis of epithelioid mesothelioma: an update. Ordóñez NG Arch Pathol Lab Med; 2005 Nov; 129(11):1407-14. PubMed ID: 16253021 [TBL] [Abstract][Full Text] [Related]
27. Diffuse membranous immunoreactivity for podoplanin (D2-40) distinguishes primary and metastatic seminomas from other germ cell tumors and metastatic neoplasms. Yu H; Pinkus GS; Hornick JL Am J Clin Pathol; 2007 Nov; 128(5):767-75. PubMed ID: 17951198 [TBL] [Abstract][Full Text] [Related]
28. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma. Cao D; Guo S; Allan RW; Molberg KH; Peng Y Am J Surg Pathol; 2009 Jun; 33(6):894-904. PubMed ID: 19295406 [TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical detection of the lymphatic marker podoplanin in diverse types of human cancer cells using a novel antibody. Kono T; Shimoda M; Takahashi M; Matsumoto K; Yoshimoto T; Mizutani M; Tabata C; Okoshi K; Wada H; Kubo H Int J Oncol; 2007 Sep; 31(3):501-8. PubMed ID: 17671675 [TBL] [Abstract][Full Text] [Related]
30. Glypican 3: a novel marker in testicular germ cell tumors. Zynger DL; Dimov ND; Luan C; Teh BT; Yang XJ Am J Surg Pathol; 2006 Dec; 30(12):1570-5. PubMed ID: 17122513 [TBL] [Abstract][Full Text] [Related]
31. Diagnostic utility of D2-40 and podoplanin in effusion cell blocks. Bhalla R; Siddiqui MT; Mandich D; Cartun RW; Fiel-Gan MD; Nassar A; Mandavilli SR Diagn Cytopathol; 2007 Jun; 35(6):342-7. PubMed ID: 17497664 [TBL] [Abstract][Full Text] [Related]
32. Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Schacht V; Dadras SS; Johnson LA; Jackson DG; Hong YK; Detmar M Am J Pathol; 2005 Mar; 166(3):913-21. PubMed ID: 15743802 [TBL] [Abstract][Full Text] [Related]
33. Value of estrogen and progesterone receptor immunostaining in distinguishing between peritoneal mesotheliomas and serous carcinomas. Ordóñez NG Hum Pathol; 2005 Nov; 36(11):1163-7. PubMed ID: 16260268 [TBL] [Abstract][Full Text] [Related]
34. Lymphatic vessel density in pulmonary adenocarcinoma immunohistochemically evaluated with anti-podoplanin or anti-D2-40 antibody is correlated with lymphatic invasion or lymph node metastases. Adachi Y; Nakamura H; Kitamura Y; Taniguchi Y; Araki K; Shomori K; Horie Y; Kurozawa Y; Ito H; Hayashi K Pathol Int; 2007 Apr; 57(4):171-7. PubMed ID: 17316411 [TBL] [Abstract][Full Text] [Related]
35. Pleomorphic carcinoma of the lung expressing podoplanin and calretinin. Kenmotsu H; Ishii G; Nagai K; Nakao M; Kawase A; Kojika M; Murata Y; Nishiwaki Y; Ochiai A Pathol Int; 2008 Dec; 58(12):771-4. PubMed ID: 19067851 [TBL] [Abstract][Full Text] [Related]
36. Diagnostic implications of podoplanin expression in peripheral nerve sheath neoplasms. Jokinen CH; Dadras SS; Goldblum JR; van de Rijn M; West RB; Rubin BP Am J Clin Pathol; 2008 Jun; 129(6):886-93. PubMed ID: 18480004 [TBL] [Abstract][Full Text] [Related]
37. The role of podoplanin in tumor progression and metastasis. Raica M; Cimpean AM; Ribatti D Anticancer Res; 2008; 28(5B):2997-3006. PubMed ID: 19031946 [TBL] [Abstract][Full Text] [Related]
38. Value of immunohistochemistry in distinguishing peritoneal mesothelioma from serous carcinoma of the ovary and peritoneum: a review and update. Ordóñez NG Adv Anat Pathol; 2006 Jan; 13(1):16-25. PubMed ID: 16462153 [TBL] [Abstract][Full Text] [Related]
39. A useful antibody panel for differential diagnosis between peritoneal mesothelioma and ovarian serous carcinoma in Japanese cases. Takeshima Y; Amatya VJ; Kushitani K; Inai K Am J Clin Pathol; 2008 Nov; 130(5):771-9. PubMed ID: 18854270 [TBL] [Abstract][Full Text] [Related]
40. Podoplanin expression in fibrous histiocytomas and cellular neurothekeomas. Kaddu S; Leinweber B Am J Dermatopathol; 2009 Apr; 31(2):137-9. PubMed ID: 19318798 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]